With the release of two COVID-19 vaccinations—one from Pfizer and one from Moderna—right around the corner, some employers are considering requiring their employees to be immunized as soon as the vaccine is widely available. Employers are…

The American Dental Association (ADA) is urging the United States Centers for Disease Control and Prevention (CDC) to include oral health professionals in the first phase of COVID-19 vaccine distribution along with other healthcare…

The American Dental Association (ADA) states that dental practices should remain open to serve their patients during the resurgence of the global pandemic, emphasizing the fact that dental care is essential. With the number of COVID-19…

In healthcare and, more specifically, the dental field, musculoskeletal disorders (MSDs) are one of the most critical occupational health concerns affecting clinicians. The prevalence of chronic musculoskeletal pain among dental hygienists…

While there is no cure for COVID-19, several treatments have become available to reduce morbidity and mortality among those who experience severe illness following infection with SARS-CoV-2. In the United States, the antiviral medication,…

A University of Oxford study of British healthcare workers found that re-infection with SARS-CoV-2 is unlikely for at least 6 months post-infection. Study authors suggest that most people who recover from COVID-19 will not be re-infected,…

With more than 1 million cases of COVID-19 reported in the United States over the past week, the US Centers for Disease Control and Prevention (CDC) recommends that Americans stay home this Thanksgiving and only celebrate with those in…

On November 17, the United States Food and Drug Administration (FDA) issued an emergency use authorization for the first COVID-19 diagnostic self-test that can be taken at home. Manufactured by Lucira, the COVID-19 All-In-One Test Kit uses…

A recent Gallup poll conducted October 19 to November 1 shows that the number of Americans willing to get a COVID-19 vaccination is increasing. The percentage of those who will take such an immunization once available has risen to 58%, up…

Moderna just released data on the results of its large-scale clinical trial on a COVID-19 vaccine, and the results are something to celebrate; the vaccine demonstrated 94.5% effectiveness with few safety concerns. Similar to the vaccine…